Pnc Financial Services Group, Inc. Bluebird Bio, Inc. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 980 shares of BLUE stock, worth $8,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares

980

Previous 1,730 43.35%

Holding current value

$8,183

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.47 - $1.35 $352 - $1,012	-750 Reduced 43.35%	980 $0
Q1 2024 May 10, 2024	BUY	$0.91 - $1.75 $495 - $953	545 Added 45.99%	1,730 $2,000
Q4 2023 Feb 09, 2024	SELL	$1.32 - $4.83 $2,356 - $8,621	-1,785 Reduced 60.1%	1,185 $1,000
Q3 2023 Nov 13, 2023	SELL	$3.02 - $4.05 $887 - $1,190	-294 Reduced 9.01%	2,970 $9,000
Q2 2023 Aug 11, 2023	BUY	$2.79 - $5.03 $4,904 - $8,842	1,758 Added 116.73%	3,264 $10,000
Q1 2023 May 15, 2023	SELL	$3.14 - $8.22 $2,763 - $7,233	-880 Reduced 36.88%	1,506 $4,000
Q4 2022 Feb 10, 2023	BUY	$5.77 - $8.49 $5,077 - $7,471	880 Added 58.43%	2,386 $16,000
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $2,616 - $4,654	-890 Reduced 37.15%	1,506 $6,000
Q1 2022 May 12, 2022	BUY	$4.07 - $10.6 $4,546 - $11,840	1,117 Added 87.33%	2,396 $11,000
Q4 2021 Feb 11, 2022	BUY	$8.96 - $16.31 $1,684 - $3,066	188 Added 17.23%	1,279 $12,000
Q3 2021 Nov 05, 2021	BUY	$11.24 - $21.0 $2,394 - $4,473	213 Added 24.26%	1,091 $13,000
Q2 2021 Aug 06, 2021	BUY	$18.04 - $22.09 $3,337 - $4,086	185 Added 26.7%	878 $18,000
Q1 2021 May 07, 2021	BUY	$16.59 - $33.89 $2,057 - $4,202	124 Added 21.79%	693 $13,000
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $2,310 - $3,185	84 Added 17.32%	569 $15,000
Q3 2020 Nov 06, 2020	BUY	$34.44 - $43.75 $12,639 - $16,056	367 Added 311.02%	485 $16,000
Q2 2020 Aug 07, 2020	BUY	$27.12 - $45.97 $515 - $873	19 Added 19.19%	118 $4,000
Q1 2020 May 08, 2020	SELL	$26.16 - $63.5 $14,885 - $36,131	-569 Reduced 85.18%	99 $2,000
Q4 2019 Feb 07, 2020	BUY	$46.96 - $61.67 $4,602 - $6,043	98 Added 17.19%	668 $37,000
Q3 2019 Nov 08, 2019	SELL	$59.47 - $93.1 $12,488 - $19,551	-210 Reduced 26.92%	570 $33,000
Q2 2019 Aug 09, 2019	SELL	$75.84 - $105.21 $455 - $631	-6 Reduced 0.76%	780 $0
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $1,933 - $3,123	30 Added 3.97%	786 $0
Q4 2018 Feb 08, 2019	SELL	$59.1 - $93.26 $17,079 - $26,952	-289 Reduced 27.66%	756 $48,000
Q3 2018 Nov 09, 2018	SELL	$88.86 - $117.49 $81,573 - $107,855	-918 Reduced 46.77%	1,045 $0
Q2 2018 Aug 10, 2018	SELL	$99.64 - $127.59 $2.09 Million - $2.67 Million	-20,928 Reduced 91.42%	1,963 $0
Q1 2018 May 11, 2018	SELL	$105.8 - $150.94 $7,300 - $10,414	-69 Reduced 0.3%	22,891 $0
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $1.68 Million - $2.7 Million	20,620 Added 881.2%	22,960 $0
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $135,111 - $213,922	2,340	2,340 $0

Others Institutions Holding BLUE

# of Institutions

146

Shares Held

63.3M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $644M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Bluebird Bio, Inc. Transaction History